QMDT Quick Med Technologies Inc (CE)

Quick-Med Technologies, Inc. (OTCQB:QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that Dr. Bernd Liesenfeld, principal scientist at Quick-Med, will deliver a podium presentation on Quick-Med's novel Stay Fresh Antimicrobial Technology at the 2012 International Conference, organized by the American Association of Textile Chemists and Colorists (AATCC).

Dr. Liesenfeld's paper, "Antimicrobial and Antifungal Fabric Finishing Based on Peroxide Chemistry," will highlight the significant advances that researchers at Quick-Med are making in achieving extraordinary durability and antimicrobial efficacy in applying the Company's proprietary Stay Fresh Antimicrobial to a range of natural and synthetic fabrics.

Stay Fresh represents a breakthrough antimicrobial technology. What makes Stay Fresh different from other antimicrobials is its chemistry and extraordinary durability. The active ingredient is hydrogen peroxide – the ingredient that provides the gentle disinfecting and bleaching action in today's generation of color-safe, alternative bleaches. This advance is made possible by Quick-Med's development of the first commercially viable technology for bonding the active ingredient onto the textile.

This year's AATCC International Conference takes place on March 21-23 in Charlotte, North Carolina. Dr. Liesenfeld's presentation takes place on Friday, March 23 at 9:30 a.m. To schedule a meeting with Dr. Liesenfeld, please contact us at (888) 835-2211 ext. 2 or email Dr. Liesenfeld directly at: bliesenfeld@quickmedtech.com.  

About Stay Fresh

Stay Fresh is Quick-Med's newest technology platform, offering textile companies a breakthrough in antimicrobial protection to enhance and differentiate their products. Today's leading freshness-enhancing textile technologies are limited in their ability to destroy certain bacteria and unable to maintain efficacy throughout the life of laundered textiles. Stay Fresh is designed to overcome these limitations by providing cost-effective, durable, and sustained antimicrobial protection.

Stay Fresh is the only antimicrobial technology containing hydrogen peroxide approved by EPA for antimicrobial preservation of textiles. The safe, eco-friendly active ingredient in Stay Fresh is bonded to fibers or fabrics to retain its efficacy for as many as 100 laundering cycles, in hot or cold water. Stay Fresh provides durable, long-lasting antimicrobial efficacy.

About Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc. is a life sciences company that is developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. In addition to NIMBUS, Quick-Med's Stay Fresh® technology provides highly durable antimicrobial protection for laundered apparel and other textile applications and its NimbuDerm™ technology is being developed as a long-lasting hand sanitizer. For more information, see: www.quickmedtech.com.

The Quick-Med Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8260

About AATCC

The American Association of Textile Chemists and Colorists (AATCC) is the world's leading not-for-profit association serving textile professionals. AATCC provides test method development, quality control materials, and professional networking for thousands of members in 60 countries throughout the world. For more information, see: www.aatcc.org.

© 2012 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and Stay Fresh® are registered trademarks and NimbuDerm™ is a trademark of Quick-Med Technologies, Inc.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.

CONTACT: Quick-Med Technologies, Inc.
         Jerry Olderman, Ph.D.
         Vice President, Research & Development
         (888) 835.2211 Ext 104
         jolderman@quickmedtech.com